SKI Market

A+| A| A-|

Indian Indices

Sensex

75,527.95 1,695.40
( 2.30%)

Global Indices

Nasdaq

51,233.54 363.79
(0.72%)

Dow Jones

7,453.14 37.84
(0.51%)

Hang Seng

66,063.56 1,846.29
(2.88%)

Nikkei 225

10,460.24 156.36
(1.52%)

Forex

USD-INR

95.49 0.16
(0.17%)

EUR-INR

110.25 0.17
(0.15%)

GBP-INR

127.74 0.15
(0.12%)

JPY-INR

0.60 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500660

INE159A01016

132.2958859

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAXO

39.57

35925.94

EPS(TTM)

Face Value()

Div & Yield %

53.59

2.69

Back

jindal poly films ltd

Capital India Finance reports consolidated net loss of Rs 2.92 crore in the December 2025 quarter

Feb 13,2026

Net loss of Capital India Finance reported to Rs 2.92 crore in the quarter ended December 2025 as against net profit of Rs 0.69 crore during the previous quarter ended December 2024. Sales rose 8.71% to Rs 145.96 crore in the quarter ended December 2025 as against Rs 134.26 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	145.96	134.26	9
OPM %	15.67	18.38	-
PBDT	1.68	6.41	-74
PBT	-5.97	-1.62	-269
NP	-2.92	0.69	PL

75,527.95 1,695.40 ( 2.30%)

51,233.54 363.79 (0.72%)

7,453.14 37.84 (0.51%)

66,063.56 1,846.29 (2.88%)

10,460.24 156.36 (1.52%)

95.49 0.16 (0.17%)

110.25 0.17 (0.15%)

127.74 0.15 (0.12%)

0.60 0.00 (0.21%)